Callie Montez, MD
Psychiatry · Albuquerque, NMNPI 1932544723
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 46 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 13 manufacturers, the largest accounting for just 19.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $500 and has fallen 96.3% since, to $19 in 2022.
Across 46 payments — averaging $20.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Vanda Pharmaceuticals Inc.$179
- AbbVie$155
- Lundbeck LLC$113
- Eisai Inc.$93
- Adlon Therapeutics L.p.$92
- Otsuka America Pharmaceutical, Inc.$66
- plus $232 from 7 others
What the payments were for
- Food & beverage$930100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 7 | $179 |
| AbbVie(2 entities) | 8 | $155 |
| Lundbeck LLC | 7 | $113 |
| Eisai Inc. | 6 | $93 |
| Adlon Therapeutics L.p. | 4 | $92 |
| Otsuka America Pharmaceutical, Inc. | 4 | $66 |
| Sunovion Pharmaceuticals Inc. | 2 | $53 |
| Ironshore Pharmaceuticals Inc. | 2 | $46 |
| Tris Pharma Inc | 1 | $42 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $38 |
| Corium, LLC | 1 | $19 |
| Bausch Health US, LLC | 1 | $18 |
| Shire North American Group Inc | 1 | $16 |
How this compares
$930 in reported general payments places this provider in the 80th percentile of 174 psychiatry providers in New Mexico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| AustedoDeutetrabenazine | 18 | $128,008 |
| Invega SustennaPaliperidone Palmitate | 25 | $77,735 |
| Quetiapine Fumarate | 54 | $4,559 |
| Paliperidone ErPaliperidone | 12 | $3,190 |
| Divalproex Sodium ErDivalproex Sodium | 23 | $1,737 |
| Aripiprazole | 38 | $1,532 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 39 | $1,469 |
| Ziprasidone Hcl | 19 | $1,283 |
| Olanzapine | 69 | $1,231 |
| Haloperidol Decanoate | 14 | $991 |
| Lamotrigine | 51 | $803 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 38 | $533 |
| Duloxetine Hcl | 25 | $512 |
| Trazodone Hcl | 64 | $499 |
| Bupropion Hcl SrBupropion Hcl | 25 | $438 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Albuquerque
- Patricio EscalonaAlbuquerque$487K
- Mauricio TohenAlbuquerque$160K
- Shiva SharmaAlbuquerque$140K
- Javier VeraAlbuquerque$8K
- Nancy MartinAlbuquerque$6K
- Reuben SutterAlbuquerque$5K
- Swala AbramsAlbuquerque$3K
- David EarlAlbuquerque$3K
- Ronald RomanikAlbuquerque$2K
- Anthony HolzgangAlbuquerque$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.